GlassScriptPhysician profile
Patricia A Walker
NPI 1568558609
$9,155.59
in general payments reported to CMS, 2019-2025
11 companies · $8,776 in 2025
The $8,776 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.36 · 2020: $15.74 · 2021: $58.81 · 2022: $111 · 2023: $26.99 · 2024: $152 · 2025: $8,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,235 · Food and Beverage: $475 · Travel and Lodging: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,235.00 |
| Food and Beverage | $474.52 |
| Travel and Lodging | $245.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $8,933.15 | 2020-2025 | Trikafta |
| Mylan Specialty L.P. | $111.18 | 2022 | |
| Nestle Healthcare Nutrition INC. | $38.17 | 2021 | |
| Baxter Healthcare | $36.43 | 2025 | Hillrom - Life 2000 Ventilation System |
| Alcresta Therapeutics, INC. | $22.30 | 2024 | Relizorb |
| Advanced Respiratory, INC | $14.36 | 2019 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.